Navigation Links
Zimmer Introduces First Porous Metal Interbody Implant for Lumbar Spine in the United States

WARSAW, Ind., June 26, 2012 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal health, today introduced the TM Ardis™ Interbody System, the first application of a porous metal implant with an interbody indication for the lumbar spine in the United States.  The TM Ardis System extends the applications of Zimmer's proprietary Trabecular Metal ™ Technology, which is currently used across the Company's portfolio, including in the cervical spine.

"Products like the TM Ardis System with Trabecular Metal Technology align with Zimmer's strategy to develop innovative technologies that are designed to restore patient mobility, alleviate pain and improve the quality of life for patients around the world," said Steve Healy, President, Zimmer Spine.  "Our objective is to create personalized therapies, procedures and implants to improve patient outcomes while lowering healthcare costs."

Trabecular Metal Technology is exclusive to Zimmer and displays elasticity properties similar to cancellous bone, supporting boney in-growth between the implant and the bone which promotes biologic fixation.  Leveraging the unique properties of this exciting material, Zimmer designed the TM Ardis Implant with a large porous surface area available for boney in-growth which supports biologic fixation and more even load distribution which has the potential to decrease the risk of stress shielding.

Trabecular Metal Material is a highly-porous material that is similar to the structure, function and physiology of trabecular bone.  No other porous metal material is supported by the amount of peer-reviewed, published clinical data of Trabecular Metal Technology and its history of clinical success in reconstructive orthopaedic applications.  This novel material supports boney in-growth, promoting biologic fixation, and has a stiffness similar to cancellous bone.

The TM Ardis Implant features an updated, anatomical shape which allows the implant to be inserted into the disc space more easily. 

The TM Ardis Interbody System has one of the most extensive size offerings on the market to allow the implant to more closely match a variety of patient anatomies.  The TM Ardis Interbody System is available in 40 sizes, with implants available in three lengths, two widths, and eight heights.

The TM Ardis Interbody System is indicated for use with autogenous bone graft as an intervertebral body fusion device at one or two contiguous levels in the lumbosacral region (L2-S1) in the treatment of degenerative disc disease (DDD) with up to Grade 1 spondylolisthesis or retrolisthesis at the involved level(s).  DDD is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies.  Patients with previous non-fusion spinal surgery at involved level may be treated with the device.  Patients should be skeletally mature and have had six months of non-operative treatment.  The TM Ardis Interbody System is implanted using a posterior or transforaminal approach and is intended to be used singly or in pairs with supplemental fixation.

About Zimmer
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products.  Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries.  Zimmer's 2011 sales were approximately $4.5 billion.  The Company is supported by the efforts of more than 8,500 employees worldwide.  For more information, please visit our website at

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management.  Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially.  For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission.  We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports.  Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate.  This cautionary statement is applicable to all forward-looking statements contained in this document.

ZS-SA0602 Rev A per DCR 9712

©2012 Zimmer Spine, Inc.

SOURCE Zimmer Holdings, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Zimmer Announces Quarterly Dividend for Second Quarter of 2012
2. Cook Medical, Zimmer, Pro-Dex & J&J to Share Innovative Social Media Approaches to Marketing Device Products in Minneapolis
3. PharmaNet/i3 Introduces PharmaNet/i3 Strategic Resourcing
4. PeriGen, Inc. Introduces New, Advanced Perinatal System at National Perinatal Nursing Convention
5. HealthONE® Introduces the Colorado Center for Robotic Surgery(SM)
6. ConvaTec Introduces Enhanced Flexi-Seal® SIGNAL® FMS
7. IDEV Technologies Introduces SurePath™ Guidewires
8. Velos, Inc. Introduces Mobile App for Oncology Adverse Events and Graft-Versus-Host Disease at 2012 ASCO Annual Meeting
9. Rochester Medical Introduces Magic3® Coude Tip Hydrophilic Intermittent Catheter
10. Richard Wolf Medical Instruments introduces groundbreaking 5514 Endocam Performance HD
11. Pernix Therapeutics Introduces Omeclamox-Pak®, First Product in Gastroenterology Portfolio
Post Your Comments:
(Date:11/26/2015)... 2015 ) ... "Radioimmunoassay Market by Type (Reagents & Kits, ... Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), ... report to their offering. --> ... of the "Radioimmunoassay Market by Type ...
(Date:11/25/2015)... Nov. 25, 2015 ... of the "Global Brain Monitoring Devices ... --> ) has announced ... Monitoring Devices Market 2015-2019" report to ... Markets ( ) has announced the ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... Dental Association meeting in Washington D.C. revolved around the fact that proper dental care, ... The talk stressed the link between periodontal disease (more commonly referred to as gum ...
(Date:11/27/2015)... ... ... The rapid speed at which Americans are aging is ... needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming more prevalent. Health ... of this equation: 80 percent of medical care occurs in the home, by ...
(Date:11/27/2015)... PA (PRWEB) , ... November 27, 2015 , ... ... how filthy the toilets were," said an inventor from Hillside, N.J. "Many people ... improved seat cover so that individuals will always be protected from germs." , ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ProSidebar: ... in Final Cut Pro X. With ProSidebar: Fasion, video editors can easily add ... ProSidebar as a minimalist title opener. Utilize presets featuring self-animating drop zones, lines, ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec Solutions ... SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end users of ... SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership status demonstrates ...
Breaking Medicine News(10 mins):